Interstitial lung diseases (ILD) represent a group of heterogeneous parenchymal lung
disorders with complex pathophysiology, characterized by different clinical and radiological …

Interstitial lung diseases (ILDs) comprise an heterogenous group of more than 200
pulmonary disorders characterized by lung architectural distortion, with variable amount of …

As our understanding of the pathobiology and natural history of the various forms of
interstitial lung disease (ILD) has evolved, so have our approaches to treating this …

The last 2 years have presented previously unforeseen challenges in pulmonary medicine.
Despite the significant impact of the SARS‐CoV‐2 pandemic on patients, clinicians and …

Background: Interstitial lung disease (ILD) includes a diverse group of respiratory conditions
characterised by inflammation and fibrosis of the interstitium. Worsening hypoxia and …

Abstract Purpose of Review Interstitial lung diseases (ILDs) cause unpredictable degrees of
fibrosis and inflammation in the lungs leading to functional decline and varying symptom …

Fibrosing interstitial lung diseases (ILDs) are a large group of diseases triggered by external
or internal stimuli that can have similar outcomes, ie lung fibrosis. Some ILDs are primarily …

New treatment paradigms for connective tissue disease-associ... : Current Opinion in Pulmonary
Medicine New treatment paradigms for connective tissue disease-associated interstitial lung …

Interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) have an array
of immunomodulatory treatment options compared with IPF, due to their inflammatory …

Introduction: IPF is a specific form of chronic fibrosing interstitial pneumonia of unknown
cause, characterized by progressive worsening in lung function and an unfavorable …